Acrivastine and pseudoephedrine and Insulin aspart and insulin degludec Subcutaneous
Determining the interaction of Acrivastine and pseudoephedrine and Insulin aspart and insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: insulin aspart / insulin degludec
Brand name: Ryzodeg 70/30 FlexTouch
Synonyms: Insulin aspart and insulin degludec (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Insulin Aspart Injection
- Acrivastine and pseudoephedrine-Insulin Aspart Protamine and Insulin Aspart
- Acrivastine and pseudoephedrine-Insulin aspart protamine and insulin aspart Subcutaneous
- Acrivastine and pseudoephedrine-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Acrivastine and pseudoephedrine-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Acrivastine and pseudoephedrine-Insulin Aspart Protamine Injection
- Insulin aspart and insulin degludec Subcutaneous-Actamin
- Insulin aspart and insulin degludec Subcutaneous-Actamin Maximum Strength
- Insulin aspart and insulin degludec Subcutaneous-Actemra
- Insulin aspart and insulin degludec Subcutaneous-Actemra (Tocilizumab (Intravenous))
- Insulin aspart and insulin degludec Subcutaneous-Actemra (Tocilizumab Auto-Injectors)
- Insulin aspart and insulin degludec Subcutaneous-Actemra (Tocilizumab Prefilled Syringes)